Abstract
Chronic hepatitis C virus (HCV) infections are a significant health problem worldwide. The NS5B Polymerase of HCV plays a central role in virus replication and is a prime target for the discovery of new treatment options. The urgent need to develop novel anti-HCV agents has provided an impetus for understanding the structure-activity relationship of novel Hepatitis C virus (HCV) NS5B polymerase inhibitors. Towards this objective, multiple linear regression (MLR) and support vector machine (SVM) were used to develop quantitative structure-activity relationship (QSAR) models for a dataset of 34 Tetrahydrobenzothiophene derivatives. The statistical analysis showed that the models derived from both SVM (R2 = 0.9784, SE=0.2982, R2 cv = 0.92) and MLR (R2=0.9684, SE=0.1171, R2 cv= 0.955) have a good internal predictivity. The models were also validated using external test set validation and Y-scrambling, the results demonstrated that MLR has a significant predictive ability for the external dataset as compared to SVM. Also the model is found to yield reliable clues for further optimization of Tetrahydrobenzothiophene derivatives in the data set.
Keywords: Hepatitis C virus, NS5B polymerase inhibitors, QSAR, support vector machine, tetrahydrobenzothiophene.
Current Bioinformatics
Title:Credential Role of van der Waal Volumes and Atomic Masses in Modeling Hepatitis C Virus NS5B Polymerase Inhibition by Tetrahydrobenzo- Thiophenes Using SVM and MLR Aided QSAR Studies
Volume: 8 Issue: 4
Author(s): Kirti Khuntwal, Mukesh Yadav, Anuraj Nayarisseri, Shobha Joshi, Deepika Sharma and Smita Suhane
Affiliation:
Keywords: Hepatitis C virus, NS5B polymerase inhibitors, QSAR, support vector machine, tetrahydrobenzothiophene.
Abstract: Chronic hepatitis C virus (HCV) infections are a significant health problem worldwide. The NS5B Polymerase of HCV plays a central role in virus replication and is a prime target for the discovery of new treatment options. The urgent need to develop novel anti-HCV agents has provided an impetus for understanding the structure-activity relationship of novel Hepatitis C virus (HCV) NS5B polymerase inhibitors. Towards this objective, multiple linear regression (MLR) and support vector machine (SVM) were used to develop quantitative structure-activity relationship (QSAR) models for a dataset of 34 Tetrahydrobenzothiophene derivatives. The statistical analysis showed that the models derived from both SVM (R2 = 0.9784, SE=0.2982, R2 cv = 0.92) and MLR (R2=0.9684, SE=0.1171, R2 cv= 0.955) have a good internal predictivity. The models were also validated using external test set validation and Y-scrambling, the results demonstrated that MLR has a significant predictive ability for the external dataset as compared to SVM. Also the model is found to yield reliable clues for further optimization of Tetrahydrobenzothiophene derivatives in the data set.
Export Options
About this article
Cite this article as:
Khuntwal Kirti, Yadav Mukesh, Nayarisseri Anuraj, Joshi Shobha, Sharma Deepika and Suhane Smita, Credential Role of van der Waal Volumes and Atomic Masses in Modeling Hepatitis C Virus NS5B Polymerase Inhibition by Tetrahydrobenzo- Thiophenes Using SVM and MLR Aided QSAR Studies, Current Bioinformatics 2013; 8 (4) . https://dx.doi.org/10.2174/1574893611308040008
DOI https://dx.doi.org/10.2174/1574893611308040008 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
Current Medicinal Chemistry Lentiviral Vectors: A Versatile Tool to Fight Cancer
Current Molecular Medicine Targeting Polyamine Metabolism for Finding New Drugs Against Leishmaniasis: A Review
Mini-Reviews in Medicinal Chemistry Kappa Opioids, Salvinorin A and Major Depressive Disorder
Current Neuropharmacology Proteomic Analysis of a Bioactive <i>Aloe vera</i> Extract
Current Proteomics Pharmacogenetics of Anti-Inflammatory Therapy in Asthma: Corticosteroids and Leukotriene Antagonists
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of Heart Rate Reduction in the Management of Myocarditis
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Rheumatology Reviews The Immunoproteasome: An Emerging Therapeutic Target
Current Topics in Medicinal Chemistry Function of Cytokines within the TGF-β Superfamily as Determined from Transgenic and Gene Knockout Studies in Mice
Current Molecular Medicine The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
Current Neuropharmacology Evolution of Exenatide as a Diabetes Therapeutic
Current Diabetes Reviews Pitfalls and Solutions for the Validation of Novel Drugs in Animal Models of Disease
Current Immunology Reviews (Discontinued) Multiple Roles of Fibroblast Growth Factor 21 in Metabolism
Current Pharmaceutical Design The Anti-Migraine Effects of M2000 (β-D-Mannuronic Acid) on a Patient with Rheumatoid Arthritis: Case Report
Current Clinical Pharmacology Potential Impacts of Prebiotics and Probiotics on Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Introduction of Pro and Its Analogues in the Conserved P1 Position of Trypsin Inhibitor SFTI-1 Retains Its Inhibitory Activity
Protein & Peptide Letters BHUx: A Patented Polyherbal Formulation to Prevent Hyperlipidemia and Atherosclerosis
Recent Patents on Inflammation & Allergy Drug Discovery The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research